News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Upstream Biosciences Inc. Begins Animal Efficacy Testing for Leishmaniasis Treatment



7/28/2008 9:37:32 AM

VANCOUVER, BC--(Marketwire - July 28, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) announced today that it is collaborating with Makerere University in Kampala, Uganda to evaluate the efficacy in animals of more than 20 proprietary drug candidates as potential treatments for Leishmaniasis in humans. Drug resistance has greatly reduced the effectiveness of existing Leishmaniasis treatments.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES